Cargando…
Fatty Acid Synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death
Blockade of fatty acid synthase (FASN), a key enzyme involved in de novo lipogenesis, results in robust death of ovarian cancer cells. However, known FASN inhibitors have proven to be poor therapeutic agents due to their ability to induce cachexia. Therefore, we sought to identify additional targets...
Autores principales: | Yang, Chih-Sheng, Matsuura, Kenkyo, Huang, Nai-Jia, Robeson, Alexander C., Huang, Bofu, Zhang, Liguo, Kornbluth, Sally |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340825/ https://www.ncbi.nlm.nih.gov/pubmed/25151963 http://dx.doi.org/10.1038/onc.2014.271 |
Ejemplares similares
-
Dimer‐specific immunoprecipitation of active caspase‐2 identifies TRAF proteins as novel activators
por: Robeson, Alexander C, et al.
Publicado: (2018) -
The Trim39 ubiquitin ligase inhibits APC/C(Cdh1)-mediated degradation of the Bax activator MOAP-1
por: Huang, Nai-Jia, et al.
Publicado: (2012) -
Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin
por: Matsuura, K, et al.
Publicado: (2017) -
Ceramide phosphoethanolamine synthase SMSr is a target of caspase-6 during apoptotic cell death
por: Cabukusta, Birol, et al.
Publicado: (2017) -
Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer
por: Cai, Yunlang, et al.
Publicado: (2014)